Pharmacologic therapy with flecainide for asymptomatic Wolff-Parkinson-White syndrome in an infant with severe left ventricular dyssynchrony

Cardiology in the Young
Sayo SuzukiMari Iwamoto

Abstract

Some asymptomatic patients with Wolff-Parkinson-White syndrome have severe left ventricular dyssynchrony and dysfunction. We describe a patient who was given a diagnosis of Wolff-Parkinson-White syndrome in infancy and had a complete response to pharmacologic therapy with flecainide. Our findings suggest that flecainide is a suitable resynchronisation therapy for such infants.

References

Feb 13, 2007·International Journal of Cardiology·Giovanni FazioSalvatore Pipitone
Feb 8, 2008·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Maren TomaskeUrs Bauersfeld
Sep 9, 2008·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Julia Cadrin-TourignyPaul Khairy
Apr 10, 2012·Pediatric Cardiology·Christian PaechRoman Antonin Gebauer
Aug 2, 2013·Congenital Heart Disease·Elena N KwonRonald J Kanter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.